RecruitingNCT07432932

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Studying Angiosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Royal Marsden NHS Foundation Trust
Principal Investigator
Robin Jones, MD
Royal Marsden NHS Foundation Trust
Intervention
Observational Translational Study(other)
Enrollment
800 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2028

Study locations (1)

Collaborators

Institute of Cancer Research, United Kingdom · University of Edinburgh · NHS Greater Glasgow and Clyde · University of Birmingham · University Hospital Birmingham · Cancer Research UK · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Hospitales Universitarios Virgen del Rocío · Andalusian Network for Design and Translation of Advanced Therapies · Instituto de Biomedicina de Sevilla · the Fundación Científica de la Asociación Española Contra el Cáncer · Associazione Italiana per la Ricerca sul Cancro · Freeman Hospital, UK · Liverpool Hospital · The Clatterbridge Cancer Centre NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07432932 on ClinicalTrials.gov

Other trials for Angiosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Angiosarcoma →

← Back to all trials